K240543 is an FDA 510(k) clearance for the Rapido Medical Laser (Rapido MED, Rapido Derma, Rapido ENT, Rapido Podia), a Powered Laser Surgical Instrument (Class II — Special Controls, product code GEX), submitted by Medency S.R.L. (Vicenza, IT). The FDA issued a Cleared decision on October 24, 2024, 240 days after receiving the submission on February 27, 2024. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 878.4810.
| 510(k) Number | K240543 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 27, 2024 |
| Decision Date | October 24, 2024 |
| Days to Decision | 240 days |
| Submission Type | Traditional |
| Review Panel | General & Plastic Surgery (SU) |
| Summary | Statement |
| Product Code | GEX — Powered Laser Surgical Instrument |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4810 |
| Definition | A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light. |